Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome.
暂无分享,去创建一个
P. Keck | S. McElroy | E. Gershon | H. Pope | K. Otani | S. Kaneko | Q. Cao | G. Addonizio | A. Ram | M. Redlichova
[1] K. Blum,et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. , 1994, JAMA.
[2] P. Gejman,et al. Detection of mutations and polymorphisms of Gs alpha subunit gene by denaturing gradient gel electrophoresis. , 1994, Methods in enzymology.
[3] K. Jellinger,et al. Schizophrenia: Normal Sequence in the Dopamine D2 Receptor Region that Couples to G-Proteins. DNA Polymorphisms in D2 , 1993, Neuropsychopharmacology.
[4] D. Grandy,et al. Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. , 1992, Genomics.
[5] E. Bonora,et al. Detection of Mutations in Insulin Receptor Gene by Denaturing Gradient Gel Electrophoresis , 1992, Diabetes.
[6] D. Grandy,et al. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. , 1991, Genomics.
[7] P. Keck,et al. Declining frequency of neuroleptic malignant syndrome in a hospital population. , 1991, The American journal of psychiatry.
[8] K. Otani,et al. Is the Predisposition to Neuroleptic Malignant Syndrome Genetically Transmitted? , 1991, British Journal of Psychiatry.
[9] R. Rodnitzky,et al. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy. , 1991, Archives of internal medicine.
[10] J. Davis,et al. Pharmacotherapy of Neuroleptic Malignant Syndrome , 1991 .
[11] R. Todd,et al. Analysis of the Structure and Expression of the Human Dopamine D2A Receptor Gene , 1991, Journal of neurochemistry.
[12] N. Spinner,et al. Recurrent neuroleptic malignant syndrome associated with inv dup(15) and mental retardation , 1991, Clinical genetics.
[13] B. Sommer,et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.
[14] D. Grandy,et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] P. Keck,et al. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. , 1989, The Journal of clinical psychiatry.
[16] M. Green,et al. Neuroleptic malignant syndrome. Review of response to therapy. , 1989, Archives of internal medicine.
[17] H. Hermesh,et al. Mortality from neuroleptic malignant syndrome. , 1989, The Journal of clinical psychiatry.
[18] A. Lazarus,et al. Neuroleptic malignant syndrome. , 2000, Archives of general psychiatry.
[19] G. Deuschl,et al. Neuroleptic malignant syndrome: observations on altered consciousness. , 1987, Pharmacopsychiatry.
[20] M. Caron,et al. A family of receptors coupled to guanine nucleotide regulatory proteins. , 1987, Biochemistry.
[21] P. Keck,et al. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. , 1986, The American journal of psychiatry.
[22] J. Pope. Practical Comprehensive Treatment of Anorexia Nervosa and Bulimia , 1986 .
[23] R. M. Stewart,et al. Akinetic rnutism from hypothalamic damage , 1981, Neurology.